Minimizing misclassification of hormone users at mammography screening

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Minimizing misclassification of hormone users at mammography screening. / Njor, Sisse Helle; Pedersen, Anette Tønnes; Schwartz, Walter; Hallas, Jesper; Lynge, Elsebeth.

In: International Journal of Cancer, Vol. 124, No. 9, 2009, p. 2159-65.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Njor, SH, Pedersen, AT, Schwartz, W, Hallas, J & Lynge, E 2009, 'Minimizing misclassification of hormone users at mammography screening', International Journal of Cancer, vol. 124, no. 9, pp. 2159-65. https://doi.org/10.1002/ijc.24181

APA

Njor, S. H., Pedersen, A. T., Schwartz, W., Hallas, J., & Lynge, E. (2009). Minimizing misclassification of hormone users at mammography screening. International Journal of Cancer, 124(9), 2159-65. https://doi.org/10.1002/ijc.24181

Vancouver

Njor SH, Pedersen AT, Schwartz W, Hallas J, Lynge E. Minimizing misclassification of hormone users at mammography screening. International Journal of Cancer. 2009;124(9):2159-65. https://doi.org/10.1002/ijc.24181

Author

Njor, Sisse Helle ; Pedersen, Anette Tønnes ; Schwartz, Walter ; Hallas, Jesper ; Lynge, Elsebeth. / Minimizing misclassification of hormone users at mammography screening. In: International Journal of Cancer. 2009 ; Vol. 124, No. 9. pp. 2159-65.

Bibtex

@article{8584d6909c6c11debc73000ea68e967b,
title = "Minimizing misclassification of hormone users at mammography screening",
abstract = "The aim of the study was to retrospectively determine the impact of comparing current mammograms with prior mammograms on risk of misclassification especially for hormone users. Data on mammography screening were retrieved for 1993-2005 from Fyn, Denmark. At first screen, two projections were made; at subsequent screens, one projection for fatty and two projections for mixed/dense breasts. Until June 3, 2002, 2-year-old mammograms were used for comparison, and later 4-year-old mammograms. Prescription drug data were used to identify hormone, hormone therapy (HT), use. False positive risk and interval cancer proportion dependency on age, hormone use, screen number, projection and prior mammogram were tested with logistic regression. Controlled for breast density, current HT-users had a lower risk of a false positive test 0.69 (95{\%}CI 0.55-0.86) and a lower interval cancer proportion 0.66 (95{\%}CI 0.45-0.99) when 4-year-old instead of 2-year-old mammograms were used for comparison. The use of 4-year-old instead of 2-year-old mammograms for comparison lowered the risk of false positive test in never users, but otherwise age of comparison mammogram had no impact on classification of never and past users of HT. The study indicated that misclassification at screening mammography in current users of HT can be reduced considerably, when the screening mammograms are viewed with the mammograms taken 4 years earlier. It should be stressed that these results come from a single clinic, and replication in other observational and/or experimental studies is warranted.",
author = "Njor, {Sisse Helle} and Pedersen, {Anette T{\o}nnes} and Walter Schwartz and Jesper Hallas and Elsebeth Lynge",
note = "Keywords: Aged; Breast Neoplasms; Denmark; Estrogen Replacement Therapy; False Positive Reactions; Female; Humans; Mammography; Mass Screening; Middle Aged; Predictive Value of Tests; Retrospective Studies; Risk Factors; Sensitivity and Specificity",
year = "2009",
doi = "10.1002/ijc.24181",
language = "English",
volume = "124",
pages = "2159--65",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "JohnWiley & Sons, Inc.",
number = "9",

}

RIS

TY - JOUR

T1 - Minimizing misclassification of hormone users at mammography screening

AU - Njor, Sisse Helle

AU - Pedersen, Anette Tønnes

AU - Schwartz, Walter

AU - Hallas, Jesper

AU - Lynge, Elsebeth

N1 - Keywords: Aged; Breast Neoplasms; Denmark; Estrogen Replacement Therapy; False Positive Reactions; Female; Humans; Mammography; Mass Screening; Middle Aged; Predictive Value of Tests; Retrospective Studies; Risk Factors; Sensitivity and Specificity

PY - 2009

Y1 - 2009

N2 - The aim of the study was to retrospectively determine the impact of comparing current mammograms with prior mammograms on risk of misclassification especially for hormone users. Data on mammography screening were retrieved for 1993-2005 from Fyn, Denmark. At first screen, two projections were made; at subsequent screens, one projection for fatty and two projections for mixed/dense breasts. Until June 3, 2002, 2-year-old mammograms were used for comparison, and later 4-year-old mammograms. Prescription drug data were used to identify hormone, hormone therapy (HT), use. False positive risk and interval cancer proportion dependency on age, hormone use, screen number, projection and prior mammogram were tested with logistic regression. Controlled for breast density, current HT-users had a lower risk of a false positive test 0.69 (95%CI 0.55-0.86) and a lower interval cancer proportion 0.66 (95%CI 0.45-0.99) when 4-year-old instead of 2-year-old mammograms were used for comparison. The use of 4-year-old instead of 2-year-old mammograms for comparison lowered the risk of false positive test in never users, but otherwise age of comparison mammogram had no impact on classification of never and past users of HT. The study indicated that misclassification at screening mammography in current users of HT can be reduced considerably, when the screening mammograms are viewed with the mammograms taken 4 years earlier. It should be stressed that these results come from a single clinic, and replication in other observational and/or experimental studies is warranted.

AB - The aim of the study was to retrospectively determine the impact of comparing current mammograms with prior mammograms on risk of misclassification especially for hormone users. Data on mammography screening were retrieved for 1993-2005 from Fyn, Denmark. At first screen, two projections were made; at subsequent screens, one projection for fatty and two projections for mixed/dense breasts. Until June 3, 2002, 2-year-old mammograms were used for comparison, and later 4-year-old mammograms. Prescription drug data were used to identify hormone, hormone therapy (HT), use. False positive risk and interval cancer proportion dependency on age, hormone use, screen number, projection and prior mammogram were tested with logistic regression. Controlled for breast density, current HT-users had a lower risk of a false positive test 0.69 (95%CI 0.55-0.86) and a lower interval cancer proportion 0.66 (95%CI 0.45-0.99) when 4-year-old instead of 2-year-old mammograms were used for comparison. The use of 4-year-old instead of 2-year-old mammograms for comparison lowered the risk of false positive test in never users, but otherwise age of comparison mammogram had no impact on classification of never and past users of HT. The study indicated that misclassification at screening mammography in current users of HT can be reduced considerably, when the screening mammograms are viewed with the mammograms taken 4 years earlier. It should be stressed that these results come from a single clinic, and replication in other observational and/or experimental studies is warranted.

U2 - 10.1002/ijc.24181

DO - 10.1002/ijc.24181

M3 - Journal article

VL - 124

SP - 2159

EP - 2165

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 9

ER -

ID: 14277884